Skip to main content
. 2016 Dec 28;8(23):37875–37883. doi: 10.18632/oncotarget.14333

Table 3. Clinical outcome in elderly MCRC patients according to treatment selected by age and CIRS.

Medical treatment regimens
FIr-B/FOx Triplet Doublet
Enrolled patients, No. 28 18 15
Elderly patients, No. 28 12 12
Objective Response, % 79 37.5 44
Median progression-free survival, months 11 8 8
Median overall survival, months 21 12 15